HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 81 filers reported holding HARVARD BIOSCIENCE INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $92,171 | +511.4% | 21,435 | +680.6% | 0.00% | – |
| Q2 2023 | $15,076 | -89.4% | 2,746 | -88.0% | 0.00% | – |
| Q1 2022 | $142,000 | -16.0% | 22,894 | -4.4% | 0.00% | – |
| Q4 2021 | $169,000 | -2.9% | 23,955 | -3.9% | 0.00% | – |
| Q3 2021 | $174,000 | -8.9% | 24,931 | +8.7% | 0.00% | – |
| Q2 2021 | $191,000 | +40.4% | 22,939 | -7.9% | 0.00% | – |
| Q1 2021 | $136,000 | +16.2% | 24,910 | -8.6% | 0.00% | – |
| Q4 2020 | $117,000 | +101.7% | 27,266 | +42.1% | 0.00% | – |
| Q3 2020 | $58,000 | +7.4% | 19,189 | +10.5% | 0.00% | – |
| Q2 2020 | $54,000 | – | 17,367 | +19413.5% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 89 | -100.0% | 0.00% | – |
| Q2 2019 | $481,000 | +39.0% | 241,180 | +199.8% | 0.00% | – |
| Q1 2019 | $346,000 | +0.6% | 80,455 | -26.2% | 0.00% | – |
| Q4 2018 | $344,000 | -72.6% | 109,020 | -54.4% | 0.00% | – |
| Q3 2018 | $1,254,000 | -1.3% | 239,110 | +0.4% | 0.00% | – |
| Q2 2018 | $1,271,000 | +34.5% | 238,060 | +25.9% | 0.00% | – |
| Q1 2018 | $945,000 | +1143.4% | 189,074 | +712.7% | 0.00% | – |
| Q4 2017 | $76,000 | +58.3% | 23,266 | +79.5% | 0.00% | – |
| Q3 2017 | $48,000 | – | 12,958 | +161875.0% | 0.00% | – |
| Q2 2017 | $0 | – | 8 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | – | 8 | -97.1% | 0.00% | – |
| Q4 2016 | $0 | – | 272 | +3300.0% | 0.00% | – |
| Q3 2016 | $0 | -100.0% | 8 | -100.0% | 0.00% | – |
| Q2 2016 | $106,000 | +657.1% | 37,126 | +660.2% | 0.00% | – |
| Q1 2016 | $14,000 | -50.0% | 4,884 | -40.8% | 0.00% | – |
| Q4 2015 | $28,000 | -17.6% | 8,252 | -11.8% | 0.00% | – |
| Q3 2015 | $34,000 | -24.4% | 9,355 | +16.2% | 0.00% | – |
| Q2 2015 | $45,000 | -80.3% | 8,054 | -79.5% | 0.00% | – |
| Q1 2015 | $228,000 | – | 39,278 | +27560.6% | 0.00% | – |
| Q4 2014 | $0 | -100.0% | 142 | -99.9% | 0.00% | – |
| Q2 2014 | $610,000 | +459.6% | 134,318 | +482.1% | 0.00% | – |
| Q1 2014 | $109,000 | +354.2% | 23,075 | +335.6% | 0.00% | – |
| Q4 2013 | $24,000 | -88.2% | 5,297 | -86.4% | 0.00% | – |
| Q3 2013 | $203,000 | – | 38,906 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Harvey Partners, LLC | 790,000 | $2,378,000 | 3.09% |
| Alambic Investment Management, L.P. | 25,398 | $76,000 | 0.83% |
| Adirondack Research & Management Inc. | 190,494 | $573,000 | 0.80% |
| Archon Capital Management LLC | 881,794 | $2,654,000 | 0.53% |
| BARD ASSOCIATES INC | 1,483,610 | $4,465,000 | 0.47% |
| DALTON GREINER HARTMAN MAHER & CO | 909,977 | $2,739,000 | 0.45% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 1,537,800 | $4,629,000 | 0.40% |
| Portolan Capital Management | 979,067 | $2,947,000 | 0.33% |
| HEARTLAND ADVISORS INC | 961,400 | $2,894,000 | 0.25% |
| Granahan Investment Management | 1,757,176 | $5,289,000 | 0.18% |